What question did this study set out to answer?

The study aims to evaluate the efficacy and tolerability of the E4/DRSP regimen in treating endometriosis-related discomfort.

April 24, 2026Open Access

Continuous estetrol/drospirenone regimen for the treatment of endometriosis-related pain: preliminary results

Key Points

The study aims to evaluate the efficacy and tolerability of the E4/DRSP regimen in treating endometriosis-related discomfort.
Implemented a continuous regimen of estetrol and drospirenone.
Assessed pain levels and tolerability among participants.
E4/DRSP effectively managed endometriosis-related pain.
Demonstrated good tolerability in patients.

Abstract

E4/DRSP demonstrated efficacy and tolerability for managing endometriosis-related pain, offering a promising option for long-term treatment. Further research is needed to confirm its impact on lesion regression and disease progression.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Dell'Aquila et al. (Wed,) studied this question.

synapsesocial.com/papers/69eb0bfa553a5433e34b566f https://doi.org/https://doi.org/10.1080/09513590.2026.2662694

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper